Observational Program of Caelyx in MBC - Prevention and Treatment of PPE and Infusion Reactions
Observational Program of Caelyx in MBC - Prevention and Treatment of PPE and Infusion Reactions
This is a study to evaluate the safety and tolerability of Caelyx used for the treatment of metastatic breast cancer (MBC), focusing on infusion reaction and palmar-plantar erythrodysesthesia (PPE).
Patients selected by investigator according to clinical routine
Inclusion Criteria:
Exclusion Criteria: